Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes
Sarah J. Richardson(University of Exeter), Noel G. Morgan(University of Exeter), Pia Leete(University of Exeter), Alberto Pugliese(University of Miami), Matthias von Herrath(Novo Nordisk (Denmark)), Marie Zeissler(University of Exeter), Mark A. Russell(University of Exeter), Mark A. Atkinson(University of Florida), Teresa Rodríguez-Calvo(La Jolla Institute for Immunology), Clayton E. Mathews(University of Florida), John S. Kaddis(City of Hope), Ivan Gerling(University of Tennessee Health Science Center), Lars Krogvold(Oslo University Hospital), Knut Dahl‐Jørgensen(Oslo University Hospital)
Cited by 304
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k